Michael Wittenberg

2.3k total citations
24 papers, 780 citations indexed

About

Michael Wittenberg is a scholar working on Organic Chemistry, Neurology and Electronic, Optical and Magnetic Materials. According to data from OpenAlex, Michael Wittenberg has authored 24 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Neurology and 6 papers in Electronic, Optical and Magnetic Materials. Recurrent topics in Michael Wittenberg's work include Surfactants and Colloidal Systems (5 papers), Liquid Crystal Research Advancements (5 papers) and Neurological disorders and treatments (4 papers). Michael Wittenberg is often cited by papers focused on Surfactants and Colloidal Systems (5 papers), Liquid Crystal Research Advancements (5 papers) and Neurological disorders and treatments (4 papers). Michael Wittenberg collaborates with scholars based in Germany, France and Sweden. Michael Wittenberg's co-authors include Joachim H. Wendorff, Carmen Schade‐Brittinger, Anja Rinke, Thomas M. Gress, Behnaz Aminossadati, Rudolf Arnold, Günter Lattermann, Hans‐Helge Müller, Carsten Tschierske and Reinhard Festag and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Clinical Oncology.

In The Last Decade

Michael Wittenberg

22 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Wittenberg Germany 17 303 294 261 155 131 24 780
Seunghyun Jeon South Korea 14 69 0.2× 152 0.5× 187 0.7× 38 0.2× 25 0.2× 18 1.3k
Carlo Fumagalli Italy 22 145 0.5× 96 0.3× 89 0.3× 196 1.3× 18 0.1× 103 1.5k
Xueguo Liu China 16 56 0.2× 128 0.4× 103 0.4× 224 1.4× 51 0.4× 56 1.3k
Naijun Chen United States 20 433 1.4× 192 0.7× 18 0.1× 40 0.3× 12 0.1× 46 1.5k
Le‐Xin Wang China 14 86 0.3× 27 0.1× 34 0.1× 42 0.3× 14 0.1× 33 659
Jürgen Graf Germany 14 167 0.6× 19 0.1× 48 0.2× 150 1.0× 61 0.5× 37 829
Doris Chun United States 5 116 0.4× 40 0.1× 62 0.2× 398 2.6× 12 0.1× 5 827
Yangyang Cheng China 14 106 0.3× 21 0.1× 40 0.2× 26 0.2× 12 0.1× 62 573
Ryo Watanabe Japan 19 34 0.1× 110 0.4× 56 0.2× 23 0.1× 91 0.7× 68 1.1k
Christoph Nagel Germany 10 49 0.2× 191 0.6× 73 0.3× 131 0.8× 11 0.1× 15 618

Countries citing papers authored by Michael Wittenberg

Since Specialization
Citations

This map shows the geographic impact of Michael Wittenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wittenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wittenberg more than expected).

Fields of papers citing papers by Michael Wittenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wittenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wittenberg. The network helps show where Michael Wittenberg may publish in the future.

Co-authorship network of co-authors of Michael Wittenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wittenberg. A scholar is included among the top collaborators of Michael Wittenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wittenberg. Michael Wittenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Funck, R., Hans‐Helge Müller, Luc De Roy, et al.. (2025). Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace). EP Europace. 27(3). 3 indexed citations
2.
Steil, Regina, Thomas Ehring, Nexhmedin Morina, et al.. (2025). Complex posttraumatic stress disorder in treatment-seeking refugees: the role of trauma history, post-migration stressors and comorbid symptoms. European journal of psychotraumatology. 16(1). 2538264–2538264.
3.
Niemann, Bernd, Christian Stoppe, Michael Wittenberg, et al.. (2022). Rationale and Initiative of the Impella in Cardiac Surgery (ImCarS) Register Platform. The Thoracic and Cardiovascular Surgeon. 70(6). 458–466. 2 indexed citations
4.
Meinders, Marjan J., Stefan Lorenzl, Richard Dodel, et al.. (2020). The Prevalence and Determinants of Neuropsychiatric Symptoms in Late‐Stage Parkinsonism. Movement Disorders Clinical Practice. 7(5). 531–542. 25 indexed citations
5.
Schrag, Anette, Stefan Lorenzl, Wassilios G. Meissner, et al.. (2020). The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications. Parkinsonism & Related Disorders. 75. 91–96. 29 indexed citations
6.
Meinders, Marjan J., Stefan Lorenzl, Richard Dodel, et al.. (2020). Optimizing Treatment in Undertreated Late-Stage Parkinsonism: A Pragmatic Randomized Trial. Journal of Parkinson s Disease. 10(3). 1171–1184. 8 indexed citations
7.
Balzer‐Geldsetzer, Monika, Joaquim J. Ferreira, Per Odin, et al.. (2018). Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study. BMC Neurology. 18(1). 185–185. 26 indexed citations
8.
Canham, Steve, Will Crocombe, Maria Teresa García Morales, et al.. (2018). Requirements for Certification of ECRIN Data Centres, with Explanation and Elaboration of Standards, Version 4.0. Zenodo (CERN European Organization for Nuclear Research).
11.
Ohmann, Christian, Steve Canham, Catherine Cornu, et al.. (2013). Revising the ECRIN standard requirements for information technology and data management in clinical trials. Trials. 14(1). 97–97. 7 indexed citations
12.
Ohmann, Christian, Wolfgang Kuchinke, Steve Canham, et al.. (2011). Standard requirements for GCP-compliant data management in multinational clinical trials. Trials. 12(1). 85–85. 56 indexed citations
13.
Kuchinke, Wolfgang, Christian Ohmann, Qin Yang, et al.. (2010). Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres. Trials. 11(1). 79–79. 41 indexed citations
14.
Tschierske, Carsten, et al.. (1998). Formation of Columnar and Lamellar Lyotropic Mesophases by Facial Amphiphiles with Protic and Lipophilic Solvents. Journal of the American Chemical Society. 120(41). 10669–10675. 30 indexed citations
15.
Tschierske, Carsten, et al.. (1997). Formation of columnar mesophases by rod‐like molecules: Facial amphiphilic p‐Terphenyl derivatives. Advanced Materials. 9(7). 564–567. 22 indexed citations
16.
Tschierske, Carsten, et al.. (1997). Liquid‐Crystalline Crown Ether: Forming Columnar Mesophases by Molecular Recognition. Angewandte Chemie International Edition in English. 36(10). 1119–1121. 26 indexed citations
17.
Lattermann, Günter, et al.. (1997). Liquid crystalline derivatives of oligoethylene-amines and -amino ethers with amide, ester, urea or urethane functions. Journal of Materials Chemistry. 7(4). 607–614. 19 indexed citations
18.
Tschierske, Carsten, et al.. (1997). Flüssigkristalline Kronenether: Bildung columnarer Mesophasen durch molekulare Erkennung. Angewandte Chemie. 109(10). 1160–1163. 21 indexed citations
19.
Lattermann, Günter, et al.. (1996). Metallomesogene mit verzweigten, dendrimeren Aminoliganden. Angewandte Chemie. 108(16). 1941–1943. 16 indexed citations
20.
Lattermann, Günter, et al.. (1996). Metallomesogens with Branched, Dendrimeric Amino Ligands. Angewandte Chemie International Edition in English. 35(16). 1858–1861. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026